Association Between Metabolic Syndrome Inflammatory Biomarkers and COVID-19 Severity.

Thaidan T PhamYuanhao ZuFarhad GhamsariJanice OhFranck Mauvais-JarvisHui ZhengMichael FilbinJoshua Lee Denson

Published in: Journal of the Endocrine Society (2023)

MetS-associated severe COVID-19 is characterized by an immune signature of elevated levels of CXCL10 and IL6. Clinical trials targeting CXCL10 or IL6 antagonism in this population may be warranted.

Keyphrases

coronavirus disease
sars cov
metabolic syndrome
clinical trial
respiratory syndrome coronavirus
early onset
insulin resistance
cancer therapy
uric acid
type diabetes
cardiovascular disease
randomized controlled trial
adipose tissue
double blind